BioCentury
ARTICLE | Distillery Therapeutics

Endocrine / Metabolic

January 23, 2018 9:13 PM UTC

Patient sample and mouse studies suggest inhibiting miR-181a or NFAT5 could help treat islet autoimmunity, a precursor to Type I diabetes. In blood samples from children of Type I diabetes patients, T...